En esta página
01OKUR precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
OKUR Clase A OnKure Therapeutics, Inc. - Class A Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 4, 2026
$2,56
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,34mínimo 52 semanas
$5,38máximo 52 semanas
P/E
-0.7
BPA
$-4.40
Ingresos
$0
tus insignias
Rango 52S
$2–$5
Calificación del Analista
BUY
Precio Objetivo
$16
P/E
-0.7
ROE
-88.6%
Margen de Beneficio Neto
-1733.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
OKUR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$2.56
P/E
-0.7
BPA
$-4.40
Ingresos
$0
ROE
-88.6%
Rango 52S
$2–$5
OKUR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 7 de octubre de 2024 | 1-for-10 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$02024-12-31 → 2024-12-31
BPA$-4.402020-12-31 → 2025-12-31
Flujo de caja libre$-52M2021-12-31 → 2025-12-31
Margen neto-1733.7%2025-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | OKUR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -0.7promedio 5A ≈-10.3 | ≈-10.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | OKUR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -1833.7% | · | -1088.2% | En línea | |
| EBITDA Margin (Margen EBITDA) | -1820.6% | · | -1088.2% | En línea | |
| Net Profit Margin (Margen de Beneficio Neto) | -1733.7% | · | -988.2% | En línea | |
| ROA | -67.2%promedio 5A ≈-53.7% | ≈-53.7% | -45.0% | Débil | |
| ROE | -88.6%promedio 5A ≈43.4% | ≈43.4% | -103.7% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | OKUR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 26.7promedio 5A ≈15.2 | ≈15.2 | 10.3 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 10.0promedio 5A ≈14.6 | ≈14.6 | 7.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | OKUR | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0 | · | 0.2 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$0.00 | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
9.0%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 18, 2026 | $-0.31 | $-0.55 | 43.2% |
| 31 de marzo de 2026 | May 12, 2026 | $-1.11 | $-0.76 | -46.6% |
| 31 de diciembre de 2025 | $-0.99 | $-1.18 | 15.7% | |
| 30 de septiembre de 2025 | $-1.09 | $-1.22 | 10.8% | |
| 30 de junio de 2025 | $-1.14 | $-1.27 | 10.4% | |
| 31 de marzo de 2025 | $-1.19 | $-1.49 | 20.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $0 | |
| R&D Expense | $48M | $44M | |
| SG&A Expense | $15M | $11M | |
| Operating Expenses | $63M | $54M | |
| Operating Income | $-63M | $-54M | |
| Interest Income | $3M | $2M | |
| Income Tax | $0 | $0 | |
| Net Income | $-60M | $-53M | |
| EPS (Basic) | $-4.40 | $-15.28 | |
| EPS (Diluted) | $-4.40 | $-15.28 | |
| Shares (Basic) | 13,515,915 | 3,447,071 | |
| Shares (Diluted) | 13,515,915 | 3,447,071 | |
| EBITDA | $-63M | $-54M |
Balance general
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $59M | $111M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $61M | $113M | |
| PP&E (Net) | $618.0K | $1M | |
| PP&E (Gross) | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | |
| Other Non-current Assets | $273.0K | $109.0K | |
| Total Assets | $62M | $115M | |
| Accounts Payable | $1M | $3M | |
| Accrued Liabilities | · | $7M | |
| Current Liabilities | $6M | $11M | |
| Capital Leases | $0 | $549.0K | |
| Other Non-current Liabilities | $12.0K | · | |
| Total Liabilities | $6M | $11M | |
| Paid-in Capital | $270M | $259M | |
| Retained Earnings | $-214M | $-155M | |
| AOCI | $0 | · | |
| Stockholders' Equity | $56M | $104M | |
| Liabilities + Equity | $62M | $115M |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| D&A | $447.0K | $459.0K | |
| Stock-based Comp | $12M | $5M | |
| Other Non-cash | $-4M | $-3M | |
| Operating Cash Flow | $-52M | $-51M | |
| CapEx | $46.0K | $52.0K | |
| Investing Cash Flow | $-46.0K | $16M | |
| Financing Cash Flow | $163.0K | $116M | |
| Net Change in Cash | $-52M | $81M | |
| Free Cash Flow | $-52M | $-51M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1833.7% | · | |
| Net Margin | -1733.7% | · | |
| EBITDA Margin | -1820.6% | · | |
| ROA | -67.2% | -69.9% | |
| ROE | -88.6% | 337.4% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 10.3 | 10.7 | |
| Quick Ratio | 10.0 | 10.5 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue / Share | $0.25 | $0.00 | |
| Cash Flow / Share | $-3.83 | $-14.83 | |
| EPS (TTM) | $-4.40 | $-15.28 |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $0 | |
| Net Income TTM | $-60M | $-53M | |
| P/E | -0.7 | -0.6 | |
| Earnings Yield | -151.7% | -177.7% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $13M | $12M | $11M | $12M | $13M | $13M | $14M | $10M | $11M | $9M | $-7M | $14M | $14M | $11M | $10M | $10M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $1M | $4M | $1M | $-14M | $7M | $7M | $5M | $4M | $4M | |
| Operating Expenses | $17M | $16M | $14M | $16M | $16M | $17M | $19M | $12M | $14M | $10M | $-21M | $21M | $21M | $16M | $15M | $14M | |
| Operating Income | $-17M | $-16M | $-14M | $-16M | $-16M | $-17M | $-19M | $-12M | $-14M | $-10M | $21M | $-21M | $-21M | $-16M | $-15M | $-14M | |
| Interest Income | $2M | $458.0K | $628.0K | $804.0K | $934.0K | $1M | $1M | $174.0K | $230.0K | $295.0K | · | · | · | · | · | · | |
| Other Non-op | · | · | · | · | · | · | · | $972.0K | $1M | $1M | · | $2M | $2M | $1M | $962.0K | $833.0K | |
| Net Income | $-15M | $-15M | $-14M | $-15M | $-15M | $-16M | $-17M | $-12M | $-14M | $-10M | $19M | $-19M | $-20M | $-15M | $-14M | $-13M | |
| EPS (Basic) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| EPS (Diluted) | $-0.31 | $-1.11 | $-0.98 | $-1.09 | $-1.14 | $-1.19 | $96.46 | $-36.55 | $-44.82 | $-30.37 | $-117.48 | $-5.68 | $-0.65 | $-0.60 | $-0.56 | $-0.53 | |
| Shares (Basic) | 49,869,177 | 13,674,577 | · | 13,530,892 | 13,509,080 | 13,424,335 | · | 316,142 | 315,478 | 314,016 | · | 3,380,794 | 30,215,321 | 25,036,410 | · | 24,496,313 | |
| Shares (Diluted) | 49,869,177 | 13,674,577 | · | 13,530,892 | 13,509,080 | 13,424,335 | · | 316,142 | 315,478 | 314,016 | · | 3,380,794 | 30,215,321 | 25,036,410 | · | 24,496,313 | |
| EBITDA | $-17M | $-16M | · | $-15M | $-16M | $-17M | · | $-5M | $-6M | $-10M | · | $-21M | $-21M | $-16M | · | $-14M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $192M | $59M | $70M | $83M | $97M | $111M | $61M | $36M | $20M | $30M | $12M | $9M | $30M | $20M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | $16M | $41M | $62M | · | $114M | $134M | $63M | $81M | $54M | |
| Prepaid Expense | $1M | $5M | $2M | $1M | $1M | $2M | $2M | $331.0K | $1M | $1M | $4M | $3M | $4M | $3M | $5M | $5M | |
| Current Assets | $178M | $197M | $61M | $72M | $85M | $98M | $113M | $77M | $78M | $84M | $34M | $129M | $146M | $97M | $106M | $121M | |
| PP&E (Net) | $435.0K | $519.0K | $618.0K | $720.0K | $821.0K | $925.0K | $1M | $59.0K | $81.0K | $102.0K | $1M | $529.0K | $554.0K | $581.0K | $453.0K | $241.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | · | · | · | $555.0K | · | |
| Accum. Depreciation | $2M | $2M | $1M | $1M | $1M | $1M | $1M | · | · | · | $665.0K | · | · | · | $102.0K | · | |
| Other Non-current Assets | $401.0K | $405.0K | $273.0K | $104.0K | $116.0K | $109.0K | $109.0K | $147.0K | $153.0K | $64.0K | $58.0K | $81.0K | $79.0K | $81.0K | $84.0K | $79.0K | |
| Total Assets | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Accounts Payable | $2M | $11M | $1M | $1M | $2M | $2M | $3M | $237.0K | $64.0K | $676.0K | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | $5M | $6M | · | $725.0K | $953.0K | $2M | $4M | $11M | $12M | $8M | $5M | $7M | |
| Current Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $3M | $1M | $3M | $7M | $14M | $14M | $10M | $7M | $9M | |
| Capital Leases | $590.0K | $0 | · | $120.0K | $267.0K | $409.0K | $549.0K | $379.0K | $492.0K | $576.0K | $466.0K | $812.0K | $897.0K | $979.0K | $1M | $943.0K | |
| Other Non-current Liabilities | $12.0K | $12.0K | $12.0K | $40.0K | $40.0K | $40.0K | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $7M | $14M | $6M | $6M | $8M | $9M | $11M | $4M | $2M | $3M | $8M | $15M | $16M | $12M | $8M | $10M | |
| Common Stock | · | · | · | · | · | · | · | $0 | $3.0K | $3.0K | · | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $417M | $414M | $270M | $267M | $264M | $261M | $259M | $310M | $309M | $308M | $209.0K | $305M | $304M | $239M | $237M | $235M | |
| Retained Earnings | $-245M | $-229M | $-214M | $-201M | $-186M | $-171M | $-155M | $-236M | $-232M | $-227M | $-102M | $-191M | $-171M | $-152M | $-137M | $-123M | |
| AOCI | $-13.0K | · | · | · | · | · | · | $2.0K | $-13.0K | $-12.0K | · | $-21.0K | $-31.0K | $12.0K | $-43.0K | $-26.0K | |
| Stockholders' Equity | $172M | $184M | $56M | $66M | $78M | $91M | $104M | $74M | $77M | $81M | $-102M | $115M | $133M | $87M | $100M | $112M | |
| Liabilities + Equity | $179M | $199M | $62M | $73M | $86M | $100M | $115M | $78M | $79M | $85M | $36M | $130M | $148M | $99M | $108M | $123M | |
| Shares Outstanding | · | · | · | · | · | · | · | 3,343,525 | 33,420,808 | 33,420,808 | · | 33,872,166 | 33,800,788 | 25,107,430 | 24,699,553 | 24,529,646 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $104.0K | $104.0K | $108.0K | $117.0K | $118.0K | $116.0K | $114.0K | $115.0K | $114.0K | $291.0K | $43.0K | $42.0K | $41.0K | $25.0K | $22.0K | |
| Stock-based Comp | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $-70.0K | $842.0K | $107.0K | $-4M | $1M | $1M | $1M | $1M | $990.0K | |
| Other Non-cash | · | $-665.0K | · | · | · | $-943.0K | · | · | · | $-14M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-10M | $-13M | $-12M | $-13M | $-13M | $-14M | $-23M | $58.0K | $4M | $-11M | $9M | $-19M | $-16M | $-9M | $-16M | $-11M | |
| CapEx | $3.0K | $5.0K | $9.0K | $6.0K | $13.0K | $18.0K | $15.0K | $35.0K | $10.0K | $9.0K | $50.0K | $19.0K | $5.0K | $172.0K | $250.0K | $28.0K | |
| Investing Cash Flow | $-10M | $-5.0K | $-9.0K | $-6.0K | $-13.0K | $-18.0K | $16M | $-36M | $-14M | $-9.0K | $29M | $21M | $-69M | $19M | $-27M | $-45M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-5M | $146M | $240.0K | $0 | $0 | $-77.0K | $110M | $6M | $6M | $10.0K | $-12M | $173.0K | $64M | $1M | $325.0K | $97.0K | |
| Net Change in Cash | $-26M | $133M | $-11M | $-13M | $-13M | $-14M | $103M | $-30M | $-4M | $-11M | $27M | $3M | $-21M | $10M | $-42M | $-56M | |
| Free Cash Flow | · | $-13M | · | · | · | $-14M | · | · | · | · | · | · | · | $-9M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1088.2% | -3409.4% | · | -1932.8% | -1747.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -988.2% | -3309.4% | · | -1832.8% | -1647.8% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1088.2% | -3386.7% | · | -1919.3% | -1735.2% | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -11.6% | -10.2% | · | -19.5% | -18.7% | -17.3% | · | -3.5% | -4.7% | -9.2% | · | -15.2% | -13.9% | -12.4% | · | -9.1% | |
| ROE | -12.3% | -11.0% | · | -20.9% | -19.9% | -18.5% | · | -3.9% | -5.1% | -10.0% | · | -16.9% | -15.2% | -13.6% | · | -9.7% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.7 | 13.8 | · | 11.4 | 11.1 | 11.2 | · | 23.7 | 57.9 | 29.8 | · | 9.5 | 10.7 | 9.3 | · | 12.8 | |
| Quick Ratio | 25.1 | 13.4 | · | 11.3 | 11.0 | 11.0 | · | 23.6 | 56.9 | 29.4 | · | 9.3 | 10.4 | 8.9 | · | 12.3 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | $22.14 | $2.30 | $2.43 | · | $3.39 | $3.92 | $3.47 | · | $4.57 | |
| Revenue / Share | $0.03 | $0.03 | · | $0.06 | $0.07 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.95 | · | · | · | $-1.04 | · | · | · | $-0.63 | · | · | · | $-0.36 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $18.15 | $1.08 | $0.61 | · | $0.35 | $0.27 | $1.21 | · | $2.53 | |
| EPS (TTM) | $-3.49 | $-4.32 | · | $93.04 | $57.58 | $13.90 | · | $-229.22 | $-198.35 | $-154.18 | · | $-7.49 | $-2.34 | $-2.19 | · | $0.68 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-59M | $-59M | · | $-63M | $-60M | $-59M | · | $-17M | $-24M | $-30M | · | $-67M | $-61M | $-54M | · | $-49M | |
| Market Cap | · | · | · | · | · | · | · | $57M | $505M | $555M | · | $2.58B | $2.22B | $1.50B | · | $822M | |
| P/E | -1.3 | -1.0 | · | 0.0 | 0.0 | 0.3 | · | -0.1 | -0.1 | -0.1 | · | -10.2 | -28.0 | -27.3 | · | 49.3 | |
| P/B | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Tangible Book | · | · | · | · | · | · | · | 0.8 | 6.6 | 6.8 | · | 22.4 | 16.7 | 17.2 | · | 7.3 | |
| P / Cash Flow | · | · | · | · | · | · | · | · | · | -26.4 | · | · | · | -165.9 | · | · | |
| Earnings Yield | -76.5% | -104.4% | · | 3383.3% | 2409.2% | 323.3% | · | -1348.3% | -1313.6% | -928.8% | · | -9.8% | -3.6% | -3.7% | · | 2.0% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | · | $0 | · | · | · |
| Margen Operativo % | -1833.7% | · | · | · | · |
| Beneficio neto | $-60M | $-53M | $-35M | $-52M | $-40M |
| EPS Diluido | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 10.3 | 10.7 | · | 14.9 | 24.8 |
| Ratio Rápido | 10.0 | 10.5 | · | 14.2 | 23.8 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-52M | $-51M | · | $-48M | $-38M |
Propietarios institucionales (13F) 78 declarantes · $160.2M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
78
Valor en tenencia
$160.2M
Nuevas posiciones
32
Posiciones cerradas
8
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 32 (+14 vs trimestre anterior) | 8 (+1 vs trimestre anterior) | 21 (+9 vs trimestre anterior) | 9 (-5 vs trimestre anterior) | +4.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $18 232 398 | 3 998 333 | 11,38% | Acciones |
| BVF INC/IL | $14 755 148 | 3 235 778 | 9,21% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $12 948 913 | 2 839 674 | 8,08% | Acciones |
| StepStone Group LP | $11 014 934 | 2 660 612 | 6,88% | Acciones |
| ADAR1 Capital Management, LLC | $10 208 399 | 2 238 684 | 6,37% | Acciones |
| Vivo Capital, LLC | $8 790 358 | 1 927 710 | 5,49% | Acciones |
| Vestal Point Capital, LP | $8 325 187 | 1 825 699 | 5,20% | Acciones |
| BlackRock, Inc. | $6 839 294 | 1 499 845 | 4,27% | Acciones |
| Trails Edge Capital Partners, LP | $6 559 359 | 1 438 456 | 4,10% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 552 898 | 1 437 039 | 4,09% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5 493 975 | 1 204 819 | 3,43% | Acciones |
| CITADEL ADVISORS LLC | $5 412 934 | 1 187 047 | 3,38% | Acciones |
| Sio Capital Management, LLC | $4 920 080 | 1 078 965 | 3,07% | Acciones |
| Prosight Management, LP | $4 464 204 | 978 992 | 2,79% | Acciones |
| Logos Global Management LP | $4 395 179 | 963 855 | 2,74% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 303 461 | 724 438 | 2,06% | Acciones |
| NEA Management Company, LLC | $2 182 179 | 478 548 | 1,36% | Acciones |
| STATE STREET CORP | $2 114 299 | 463 662 | 1,32% | Acciones |
| Ensign Peak Advisors, Inc | $1 968 237 | 431 631 | 1,23% | Acciones |
| VANGUARD GROUP INC | $1 817 120 | 626 593 | 1,13% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 635 845 | 358 738 | 1,02% | Acciones |
| Sofinnova Investments, Inc. | $1 466 916 | 321 692 | 0,92% | Acciones |
| Carlyle Group Inc. | $1 230 721 | 269 895 | 0,77% | Acciones |
| Seven Fleet Capital Management LP | $1 098 791 | 240 963 | 0,69% | Acciones |
| Affinity Asset Advisors, LLC | $1 098 791 | 240 963 | 0,69% | Acciones |
| DV EQUITIES, LLC | $1 098 791 | 240 963 | 0,69% | Acciones |
| NORTHERN TRUST CORP | $899 127 | 197 177 | 0,56% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $810 613 | 177 766 | 0,51% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $753 207 | 165 177 | 0,47% | Acciones |
| MARSHALL WACE, LLP | $729 057 | 159 881 | 0,46% | Acciones |
| Rosalind Advisors, Inc. | $684 000 | 150 000 | 0,43% | Acciones |
| Stonepine Capital Management, LLC | $595 919 | 130 684 | 0,37% | Acciones |
| KOTLER KEVIN | $573 304 | 197 691 | 0,36% | Acciones |
| Longaeva Partners L.P. | $549 398 | 120 482 | 0,34% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $496 447 | 108 870 | 0,31% | Acciones |
| BANK OF AMERICA CORP /DE/ | $484 819 | 106 320 | 0,30% | Acciones |
| CANTOR FITZGERALD, L. P. | $456 064 | 100 014 | 0,28% | Acciones |
| UBS Group AG | $454 194 | 99 604 | 0,28% | Acciones |
| Rangeley Capital, LLC | $433 200 | 95 000 | 0,27% | Acciones |
| Aisling Capital Management LP | $404 048 | 88 607 | 0,25% | Acciones |
| Bank of New York Mellon Corp | $329 302 | 72 215 | 0,21% | Acciones |
| Walleye Capital LLC | $324 230 | 71 103 | 0,20% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $312 453 | 68 563 | 0,20% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $290 198 | 63 640 | 0,18% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $229 336 | 50 293 | 0,14% | Acciones |
| Shay Capital LLC | $228 000 | 50 000 | 0,14% | Acciones |
| PRELUDE CAPITAL MANAGEMENT, LLC | $212 916 | 46 692 | 0,13% | Acciones |
| Aldebaran Capital, LLC | $181 803 | 39 869 | 0,11% | Acciones |
| WELLS FARGO & COMPANY/MN | $166 217 | 36 451 | 0,10% | Acciones |
| Nuveen, LLC | $161 433 | 35 402 | 0,10% | Acciones |
Activistas y propietarios del %+ 5 10 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik | 7 de abril de 2026 | 19,99% | Presentación inicial | Inversión pasiva | SEC |
| ACORN BIOVENTURES, L.P., ACORN CAPITAL ADVISORS GP, LLC, Anders Hove, ACORN BIOVENTURES 2, L.P., Acorn Capital Advisors GP 2, LLC ×2 presentaciones | 30 de mayo de 2025 | 22,10% | Enmienda | M&A / venta | SEC |
| RiverVest Venture Fund III, L.P., RiverVest Venture Fund III (Ohio), L.P., RiverVest Venture Partners III (Ohio), LLC, RiverVest Venture Partners III, L.P., RiverVest Venture Partners III, LLC, RiverVest Venture Fund IV, L.P., RiverVest Venture Partners IV, L.P., RiverVest Venture Partners IV, LLC, John P. McKearn, Ph.D., Jay Schmelter, Thomas C. Melzer, Niall O'Donnell, Ph.D. | 21 de enero de 2025 | 1,55% | Enmienda | · | SEC |
| 8 de octubre de 2024 | · | Presentación inicial | · | SEC | |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 presentaciones | 8 de mayo de 2024 | · | Presentación inicial | · | SEC |
| TANG CAPITAL PARTNERS, LP, TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, Concentra Biosciences, LLC | 26 de diciembre de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Novo Holdings A/S ×5 presentaciones | 15 de diciembre de 2023 | · | Presentación inicial | · | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 30 de mayo de 2023 | · | Presentación inicial | · | SEC |
| Abingworth LLP, Abingworth Bioventures 8, LP | 20 de abril de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 19 de abril de 2021 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 28 insiders · 10 directivos · 15 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Nicholas A Saccomano | President and CEO | 21 de septiembre de 2026 S | 11 160 | 0 | 4 | $-1 252 |
| Gregory J. Flesher | President and CEO | 9 de diciembre de 2022 A | 109 600 | 0 | 0 | $0 |
| Jason A. Leverone | Chief Financial Officer | 21 de septiembre de 2026 S | 18 500 | 0 | 4 | $-4 379 |
| Michael Cruse | Chief Operating Officer | 9 de diciembre de 2022 A | 13 697 | 0 | 0 | $0 |
| Dylan Hartley | Chief Scientific Officer | 7 de agosto de 2026 A | · | 0 | 0 | $0 |
| Samuel Agresta | Chief Medical Officer | 7 de agosto de 2026 A | · | 0 | 0 | $0 |
| Ashley Hall | Chief Development Officer | 28 de agosto de 2023 M | 39 600 | 0 | 0 | $0 |
| Jennifer Lam | VP of Finance & Administration | 9 de diciembre de 2022 A | · | 0 | 0 | $0 |
| Alejandro Dorenbaum | Chief Medical Officer | 9 de diciembre de 2022 A | 30 000 | 0 | 0 | $0 |
| Wendy S. Johnson | Chief Development Officer | 14 de julio de 2021 S | 0 | 0 | 0 | $0 |
| Andrew John Phillips | Consejero | 7 de agosto de 2026 A | · | 0 | 0 | $0 |
| Valerie Malyvanh Jansen | Consejero | 7 de agosto de 2026 A | · | 0 | 0 | $0 |
| Michael R Carruthers | Consejero | 7 de agosto de 2026 A | 4 939 | 0 | 0 | $0 |
| Isaac Manke | Consejero | 7 de agosto de 2026 A | 20 583 | 0 | 0 | $0 |
| Liam Ratcliffe | Consejero | 7 de agosto de 2026 A | · | 0 | 0 | $0 |
| Roshawn A. Blunt | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Bali Muralidhar | Consejero | 6 de junio de 2023 A | 2 073 957 | 0 | 0 | $0 |
| Niall O'Donnell, Ph.D. | Consejero | 6 de junio de 2023 A | 2 188 713 | 0 | 0 | $0 |
| Eric M Dube | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Stacey Denenberg Seltzer | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Paul W. Hoelscher | Consejero | 6 de junio de 2023 A | · | 0 | 0 | $0 |
| Lon Cardon | Consejero | 8 de abril de 2021 A | · | 0 | 0 | $0 |
| Kenneth Harrison Ph.D. | Consejero | 8 de abril de 2021 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 23 de junio de 2023 S | 3 330 337 | 0 | 0 | $0 |
| Edward T. Mathers | · | 7 de agosto de 2026 A | 15 310 | 0 | 0 | $0 |
| Michael G Grey | · | 7 de agosto de 2026 A | 0 | 0 | 0 | $0 |
| Leonard Braden Michael | · | 7 de octubre de 2024 J | 102 076 | 0 | 0 | $0 |
| Vineet R. Jindal | · | 10 de diciembre de 2021 A | 36 600 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 7 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,02% | 86 965 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 12 539 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 558 665 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 32 426 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3 580 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 3 221 NS | 31 de julio de 2026 | N-PORT |
| IWN · iShares Trust | · | 226 431 SH | 11 de septiembre de 2026 | Diario |
OKUR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 12 analistas
COMPRA
Objetivo mediano
$15.00
+485,9%
4 33,3%
Compra fuerte
6 50,0%
Compra
2 16,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-29Objetivo medio $15.50 +505,5%
← Por Debajo de Todos los Objetivos
Precio Actual $2.56
Mín$11.00
Media$15.50
Máx$21.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| OKUR | · | -0.7 | · | -1733.7% | -88.6% | · |
| IMUX | · | -0.9 | · | · | · | · |
| BDTX | $139M | 6.2 | · | 31.9% | 18.3% | · |
| CADL | $310M | -7.8 | · | · | -53.7% | · |
| ANIX | $136M | -12.1 | 0.00% | · | -62.2% | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 4, 2026